Your investment timeline depends on what you're treating
Phase 2 trials in diabetes, cognition, and anti-aging applications
The Keap1Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases
I can already tell a difference in how good I feel
Semaglutide and CoQ10 complement each other well because CoQ10 lowers cardiac strain in diabetics
In type 1 diabetes (T1D), elevated circulating IL-6, IL-8, and IL-10 correlate with hyperglycemia and dyslipidemia, suggesting their potential as biomarkers for disease activity Immune cells, in particular, produce cytokines, which are tiny signaling proteins that modulate and control inflammation, hematopoiesis, and immunity